Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Vvi17g0209 ATGGCACCCTCAACCTTACAGAAAATGCTCTCCCTTGTTTCCTTGCTCCTCTTGGTTATGTTGATTTCTTCAGACCATGTTTCTTCTTATTCTAATGAAGAAACACAAGCTCTCCTCAAATGGAAAGCTACCCTTCACAACCATAACCATTCTTCCCTCCTTTCGTGGACTCTTTATCCTAACAACTTCACCAATTCTTCTACCCACCTTGGAACAGAAGTCAGTCCATGCAAATGGTACGGAATATCCTGCAACCATGCAGGGAGCGTCATCAGAATAAACCTCACAGAGTCGGGTTTAGGAGTTGGTGACTGTCCAAACCTGGAATTCATCGATTTGAGCTACAACAGGTTTCATGGTGAACTCTCTCATAACTGGGGAAGATGCCCACAACTACAAAGGCTGGAGATTGCCGGGAACAATATTACAGGGAGCATACCAGAAGATTTTGGAATCTCAACTAATCTAATCTTGCTTGATCTTTCTTCAAATCATTTGGTTGGGGAAATTCCAAAGAAAATGGGAAGTTTGACTTCTCTGTTGGGGCTGATATTGAATGACAACCAACTTTCCGGGAGTATTCCTCCTGAACTTGGATCGCTATCCAAGAGCCACAAAGTTGTGTTTATTATCATATTCCCTCTTTTGGGAGCACTTGTACTTCTTTCTGCTTTCATTGGGATTTTCTTGATTGCTGAAAGAAGAGAGAGAACTCCAGAAATCGAAGAAGGTGATGTACAGAATAATCTCCTCTCAATATCAACTTTTGATGGAAGAGCAATGTATGAAGAGATTATAAAGGCCACCAAGGACTTTGATCCCATGTATTGCATCGGAAAGGGAGGGCATGGAAGCGTTTACAAAGCAGAGCTGCCATCAGGTAATATAGTAGCTGTGAAGAAGCTTCACCCATCCGACATGGATATGGCAAATCAAAAGGATTTCTTGAATAAAGTAAGGGCAATGACAGAGATCAAGCATCGAAACATTGTGAGACTTCTTGGTTTCTGTTCATATCCACGACACTCCTTTTTGGTCTATGAGTACCTTGAAAGAGGTAGCTTGGCTACAATCTTGAGCAGAGAAGAAGCTAAAAAATTGGGTTGGGCTACAAGGGTCAAGATCATCAAAGGAGTGGCTCACGCTTTGTCTTACATGCACCATGATTGCTCACCCCCGATTGTTCATCGGGATATATCGAGCAACAATATTCTGCTGGATTCTCAATATGAGGCTCATATTTCTAACTTGGGCACTGCCAAGCTTCTTAAGGTAGACTCATCAAATCAGAGCAAACTTGCAGGCACAGTCGGATACGTTGCACCAGAGCATGCTTATACAATGAAGGTCACAGAAAAAACCGATGTCTATAGCTTTGGAGTGATAGCACTGGAAGTTATCAAAGGAAGACATCCTGGAGATCAAATCTTGTCTATATCAGTTTCCCCAGAGAAGAACATAGTGTTGAAAGACATGTTGGACCCGCGACTCCCACCTCTCACACCCCAAGACGAAGGGGAAGTGGTAGCTATCATAAAGCTCGCAACTGCATGTTTAAATGCCAATCCACAATCCAGGCCAACCATGGAGATTATTTCTCAGATGTTACAGTCACCTAAAAGGACCAAAGGAACCAAATATCATGTTTCTTCTTATTCTAATGAAGAAACACAAGCTCTCCTCAAATGGAAATCTACCCTTCACAACCATAACCATTCTTTCCTCCTTTCGTGGACTCTTTATCCGGATCCTAACAACTCCACCAATTCTTCTACCCACCATGGAACGGCAACCGGTCCATGCAAATGGTATGGGATATCCTGCAACCATGCAGGGAGTCTCAAATACCTTGATCTGTCCACCAACCAGTTCTCAGGAGGGATTCCACCGGAAATTGGCCTATTAACTAACCTTGAGGTCCTGCACCTGGTTCAAAATCAGCTCAATGGTTCAATTCCTCATGAAATCGGGAGCATACCAGAAGATTTTGGAATCTCAACTAATCTAACTTTGCTTGATCTTTCTTCAAATCATTTGGTTGGGGAAATCCCAAAGAAAATGGGAAGTTTAACTTCTCTGTTGGAGCTAAAATTAAATGATAACCAACTTTCTGGAAGTATACCTCCCGAACTTGGATCTCTGTTCAGTCTTGCCCATCTCGATCTATCAGCAAACAGATTGAATGGGTCAATAACAGAGAACTTGGGTGCCTGCTTGAACTTACATTACTTGAACCTGAGCAATAACAAACTTAGCAACAGAATTCCAGCTCAGATGGGTAAGCTGAGTCACCTCTCCCAGTTAGATCTGAGTCACAACTTGCTTTCAGGAGAAATCCCACCACAAATCGAAGGTTTGGAGAGCTTAGAGAACCTTAATCTGTCCCATAACAACCTCTCCGGTTTCATCCCAAAGGCTTTCGAAGAAATGCGTGGCTTGTCTGATATTGACATATCTTACAATCAATTGCAGGGTCCCATTCCCAACAGCAAAGCATTCCGAGATGCAACCATTGAGTTGTTAAAGGGGAACAAAGATTTGTGCGGCAATGTTAAAGGGTTGCAACCTTGCAAAAATGATTCTGGAGCAGGCCAACAACCTGTCAAAAAGGGCCACAAAATTGTGTTTATAATTGTATTCCCTCTTTTGGGAGCACTTGTACTTCTTTTTGCTTTCATTGGAATTTTCTTGATTGCTGAAAGAACAAAGAGAACTCCAGAAATCGAAGAAGGTGATGTACAGAATGATCTCTTTTCAATATCAACTTTTGATGGAAGAGCAATGTATGAAGAGATTATAAAGGCCACCAAGGATTTTGATCCCATGTATTGCATCGGAAAGGGAGGGCATGGAAGCGTTTACAAAGCAGAGCTGTCGTCCGGTAATATTGTAGCTGTGAAAAAGCTTTACGCATCCGACATAGATATGGCAAATCAAAGGGATTTCTTCAATGAAGTAAGGGCACTGACAGAAATCAAACATCGGAACATTGTGAAACTTCTTGGTTTCTGTTCACATCCACGACACTCCTTTTTGGTCTATGAGTACCTTGAAAGAGGTAGCCTAGCTGCAATGTTGAGCAGAGAAGAAGCTAAAAAATTGGGTTGGGCTACAAGGATCAATATCATTAAAGGAGTGGCTCATGCTTTGTCTTACATGCACCATGATTGCTCACCCCCAATTGTTCATCGGGATATATCAAGCAACAATATTCTGCTGGATTCTCAATATGAGCCTCATATTTCTGACTTCGGCACTGCCAAGCTTCTAAAGCTAGACTCATCAAATCAAAGCGCACTTGCAGGCACATTCGGATACGTTGCACCAGAACATGCATATACAATGAAGGTCACAGAAAAAACCGATGTCTATAGTTTTGGAGTGATAACACTGGAAGTTATCAAAGGAAGACATCCTGGAGATCAAATCTTATGTGAAGCAGCATATGCTATGTATCAACTAAAACTATACATGGCGTTCTCAACCTTACAGAAAATGCTCTCCCTTGTTTCCCAGCTCTTCTTGGTTATGTTCATTGCTTCACATCATGTTTCTTCTTATTCTAATGAAGAAACACAAACTCTCCTCAAATGGAAAGCTACCCTTCACACCCATAACCATTCCTCCCTCCTTTCGTGGACTCTTTATCCTAACAACTTCACCAATTCTTCTACCCACCTTGGAACCGAAGCCAGTCCATGCAAATGGTACGGAATATCCTGCAACCATGCAGGGAGCGTCATCAGAATAAACCTCACAGAGTCGGGTTTAAGAGGTACGCTTGAAGACTTCTCATTCTCATCTTTTCCCAATCTTGCGTATGTTGATATCAGCATGAACAACCTCTCTGGTCCTATCCCACCCCAAATCGGTCTCCTCTCCAAGCTCAAATACCTTGATCTCTCTATCAACCAGTTCTCAGGAGGGATTCCGCCCGAGATTGGCCTATTAACTAATCTTGAGGTCCTGCACCTGGTTCAAAATCAGCTCAATGGTTCAATTCCTCATGAAATGGGTCAGTTGTCGTCTCTTTATGAGCTTGCTTTGTACACCAACCAACTGGAGGGTTCTATTCCTGCTTCTTTGGGTAATTTGAGCAACTTGGCCTCTTTGTATCTCTATGAAAATCAACTTTCCGGTTCCATTCCTCCAGAAATGGGAAATCTCACCAACCTTGTTGAGATATACTTGGATACCAACAATCTCACAGGTCTCATCCCTTCCACTTTCGGAAACTTGAAACGTTTAACCATGTTGTACCTATTCAACAATCAACTCTCCGGGCATATCCCACCAGAAATAGGAAATTTGAAATCTCTGCAAGGTCTAAGCCTCTACGAAAACAATCTTTCTGGTCCAATCCCTGCGTCCTTAGGTGATCTCAGTGGCCTAACCCTCCTGCATCTCTATGCCAATCAACTTTCCGGTCCCATTCCTCAAGAAATAGGTAACTTGAAGTCTCTTGTTGATCTAGAACTTTCAGAAAACCAACTCAATGGTTCCATTCCTACTTCACTGGGTAATCTGACCAACTTAGAAATTTTATTCCTCCGTGATAACCATCTTTCTGGTTACTTTCCTAAAGAAATTGGGAAACTTCATAAGTTGGTTGTGCTAGAAATCGACACAAATCGGCTGTCTGGCTCTTTACCAGAAGGCATTTGCCAAGTTGGTGACTGTCCCAACCTGGAATACATCGATTTGAGCTACAACAGGTTTCATGGCGAACTCTCTCATAACTGGGGAAGGTGCCCAAAACTACAAAGGCTGGAGATGGCCGGGAACGATATTACAGGGAGCATACCAGAAGATTTTGGAATCTCAACTAATCTAACCTTGCTTGATCTTTCTTCAAATCATTTGGTTGGGGAAATCCCAAAGAAAATGGGAAGTTTAACTTCTCTGTTGGAGCTAAAATTAAATGATAACCAACTTTCTGGGAGTATACCTCCCGAACTTGGATCACTGTTCACTCTTGCCATCTCGATCTATCAGCAAATAGATTGA 5007 0.4228 MAPSTLQKMLSLVSLLLLVMLISSDHVSSYSNEETQALLKWKATLHNHNHSSLLSWTLYPNNFTNSSTHLGTEVSPCKWYGISCNHAGSVIRINLTESGLGVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLILLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSKSHKVVFIIIFPLLGALVLLSAFIGIFLIAERRERTPEIEEGDVQNNLLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSGNIVAVKKLHPSDMDMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSLATILSREEAKKLGWATRVKIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEAHISNLGTAKLLKVDSSNQSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGVIALEVIKGRHPGDQILSISVSPEKNIVLKDMLDPRLPPLTPQDEGEVVAIIKLATACLNANPQSRPTMEIISQMLQSPKRTKGTKYHVSSYSNEETQALLKWKSTLHNHNHSFLLSWTLYPDPNNSTNSSTHHGTATGPCKWYGISCNHAGSLKYLDLSTNQFSGGIPPEIGLLTNLEVLHLVQNQLNGSIPHEIGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLELKLNDNQLSGSIPPELGSLFSLAHLDLSANRLNGSITENLGACLNLHYLNLSNNKLSNRIPAQMGKLSHLSQLDLSHNLLSGEIPPQIEGLESLENLNLSHNNLSGFIPKAFEEMRGLSDIDISYNQLQGPIPNSKAFRDATIELLKGNKDLCGNVKGLQPCKNDSGAGQQPVKKGHKIVFIIVFPLLGALVLLFAFIGIFLIAERTKRTPEIEEGDVQNDLFSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELSSGNIVAVKKLYASDIDMANQRDFFNEVRALTEIKHRNIVKLLGFCSHPRHSFLVYEYLERGSLAAMLSREEAKKLGWATRINIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEPHISDFGTAKLLKLDSSNQSALAGTFGYVAPEHAYTMKVTEKTDVYSFGVITLEVIKGRHPGDQILCEAAYAMYQLKLYMAFSTLQKMLSLVSQLFLVMFIASHHVSSYSNEETQTLLKWKATLHTHNHSSLLSWTLYPNNFTNSSTHLGTEASPCKWYGISCNHAGSVIRINLTESGLRGTLEDFSFSSFPNLAYVDISMNNLSGPIPPQIGLLSKLKYLDLSINQFSGGIPPEIGLLTNLEVLHLVQNQLNGSIPHEMGQLSSLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVEIYLDTNNLTGLIPSTFGNLKRLTMLYLFNNQLSGHIPPEIGNLKSLQGLSLYENNLSGPIPASLGDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNHLSGYFPKEIGKLHKLVVLEIDTNRLSGSLPEGICQVGDCPNLEYIDLSYNRFHGELSHNWGRCPKLQRLEMAGNDITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLELKLNDNQLSGSIPPELGSLFTLAISIYQQID* 1669
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Vvi17g0209 1668 Gene3D Transferase(Phosphotransferase) domain 1 1017 1189 - -
Vvi17g0209 1668 Gene3D Transferase(Phosphotransferase) domain 1 350 556 - -
Vvi17g0209 1668 FunFam Leucine-rich repeat receptor protein kinase EMS1 1578 1665 - -
Vvi17g0209 1668 Gene3D Ribonuclease Inhibitor 26 101 IPR032675 -
Vvi17g0209 1668 ProSitePatterns Tyrosine protein kinases specific active-site signature. 394 406 IPR008266 GO:0004672|GO:0006468
Vvi17g0209 1668 Pfam Leucine rich repeat 784 823 IPR001611 GO:0005515
Vvi17g0209 1668 Pfam Leucine rich repeat 1366 1426 IPR001611 GO:0005515
Vvi17g0209 1668 CDD STKc_IRAK 278 537 - -
Vvi17g0209 1668 Gene3D Ribonuclease Inhibitor 732 857 IPR032675 -
Vvi17g0209 1668 Gene3D Ribonuclease Inhibitor 1352 1454 IPR032675 -
Vvi17g0209 1668 FunFam Leucine-rich repeat receptor-like serine/threonine-protein kinase 902 1016 - -
Vvi17g0209 1668 Pfam Protein kinase domain 277 533 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vvi17g0209 1668 Pfam Protein kinase domain 944 1148 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vvi17g0209 1668 ProSitePatterns Protein kinases ATP-binding region signature. 278 301 IPR017441 GO:0005524
Vvi17g0209 1668 ProSitePatterns Protein kinases ATP-binding region signature. 945 968 IPR017441 GO:0005524
Vvi17g0209 1668 SUPERFAMILY L domain-like 1206 1456 - -
Vvi17g0209 1668 SUPERFAMILY L domain-like 56 204 - -
Vvi17g0209 1668 Gene3D Phosphorylase Kinase; domain 1 236 349 - -
Vvi17g0209 1668 Gene3D Phosphorylase Kinase; domain 1 902 1016 - -
Vvi17g0209 1668 FunFam Probable leucine-rich repeat receptor-like protein kinase At5g63930 1455 1552 - -
Vvi17g0209 1668 FunFam Putative leucine-rich repeat receptor-like serine/threonine-protein kinase 1017 1203 - -
Vvi17g0209 1668 Gene3D Ribonuclease Inhibitor 1455 1556 IPR032675 -
Vvi17g0209 1668 Gene3D Ribonuclease Inhibitor 557 731 IPR032675 -
Vvi17g0209 1668 Gene3D Ribonuclease Inhibitor 1557 1666 IPR032675 -
Vvi17g0209 1668 FunFam Nuclear pore complex protein NUP107 31 196 - -
Vvi17g0209 1668 SMART LRR_sd22_2 666 692 - -
Vvi17g0209 1668 SMART LRR_sd22_2 1608 1634 - -
Vvi17g0209 1668 SMART LRR_sd22_2 714 737 - -
Vvi17g0209 1668 SMART LRR_sd22_2 635 661 - -
Vvi17g0209 1668 SMART LRR_sd22_2 1485 1511 - -
Vvi17g0209 1668 SMART LRR_sd22_2 1413 1445 - -
Vvi17g0209 1668 SMART LRR_sd22_2 762 788 - -
Vvi17g0209 1668 SMART LRR_sd22_2 1365 1391 - -
Vvi17g0209 1668 SMART LRR_sd22_2 1317 1332 - -
Vvi17g0209 1668 FunFam Leucine-rich repeat receptor-like protein kinase TDR 607 859 - -
Vvi17g0209 1668 SUPERFAMILY Protein kinase-like (PK-like) 923 1171 IPR011009 -
Vvi17g0209 1668 FunFam Leucine-rich repeat receptor protein kinase MSP1 234 349 - -
Vvi17g0209 1668 SUPERFAMILY L domain-like 1375 1660 - -
Vvi17g0209 1668 FunFam Nuclear pore complex protein NUP107 1188 1356 - -
Vvi17g0209 1668 FunFam MDIS1-interacting receptor like kinase 2 350 542 - -
Vvi17g0209 1668 FunFam Probable leucine-rich repeat receptor-like protein kinase At5g63930 1357 1454 - -
Vvi17g0209 1668 PRINTS Leucine-rich repeat signature 786 799 - -
Vvi17g0209 1668 PRINTS Leucine-rich repeat signature 717 730 - -
Vvi17g0209 1668 Gene3D Ribonuclease Inhibitor 1190 1351 IPR032675 -
Vvi17g0209 1668 ProSiteProfiles Leucine-rich repeat profile. 788 809 IPR001611 GO:0005515
Vvi17g0209 1668 ProSiteProfiles Protein kinase domain profile. 272 536 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vvi17g0209 1668 ProSitePatterns Tyrosine protein kinases specific active-site signature. 1061 1073 IPR008266 GO:0004672|GO:0006468
Vvi17g0209 1668 SUPERFAMILY L domain-like 582 849 - -
Vvi17g0209 1668 SMART LRR_typ_2 1632 1656 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 1533 1557 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 786 809 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 1509 1532 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 635 659 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 177 201 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 690 713 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 714 738 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 1389 1412 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 1461 1485 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 1317 1341 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 1413 1437 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 1365 1388 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 1293 1316 IPR003591 -
Vvi17g0209 1668 SMART LRR_typ_2 762 785 IPR003591 -
Vvi17g0209 1668 SUPERFAMILY Protein kinase-like (PK-like) 256 536 IPR011009 -
Vvi17g0209 1668 ProSiteProfiles Protein kinase domain profile. 939 1210 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vvi17g0209 1668 Pfam Leucine rich repeat N-terminal domain 554 609 IPR013210 -
Vvi17g0209 1668 Pfam Leucine rich repeat N-terminal domain 1189 1242 IPR013210 -
Vvi17g0209 1668 Pfam Leucine rich repeat N-terminal domain 32 85 IPR013210 -
Vvi17g0209 1668 Gene3D Ribonuclease Inhibitor 102 208 IPR032675 -
Vvi17g0209 1668 PANTHER LEUCINE RICH REPEAT KINASE 2 548 1144 - -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Vvi17g0209 Vvi-Chr17 2055968 2088910 Dispersed/Tandem
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Vvi17g0209 617 851 Receptor kinase-like Gene Family AT4G08850 31.064 6.61e-25 111
       

Transcription factors information

Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
PK RLK-Pelle_LRR-XI-1 Vvi17g0209 Pkinase 4.2e-44 CL0016
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Vvi17g0209 - - vvi:100255980 960.674